Home › Nephrotic Syndrome › California
Nephrotic Syndrome clinical trials in California
5 studies for Nephrotic Syndrome are looking for participants at sites in California.
Cities in California
Belimumab With Rituximab for Primary Membranous Nephropathy
- University of California San Francisco, San Francisco
- Stanford University School of Medicine: Division of Nephrology, Stanford
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension, Torrance
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
- University of California San Francisco, San Francisco
RecruitingObservational study
All ages · All sexes · Updated Aug 4, 2026 · NCT06669949Atacicept in Multiple Glomerular Diseases
- Vera Therapeutics, Brisbane
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 26, 2026 · NCT06983028Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- and 1 more
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
- University of California San Francisco, San Francisco
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 24, 2025 · NCT04885179From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.